Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
Research

Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis

Tara Gomes, Andrea Mastorakos, J. Michael Paterson, Ingrid Sketris, Patricia Caetano, Simon Greaves, David Henry and for the Canadian Network for Observational Drug Effect Studies Investigators
November 22, 2017 5 (4) E800-E807; DOI: https://doi.org/10.9778/cmajo.20170104
Tara Gomes
Li Ka Shing Knowledge Institute of St. Michael's Hospital (Gomes); Institute for Clinical Evaluative Sciences (Gomes, Paterson, Greaves, Henry); Institute of Health Policy, Management, and Evaluation (Gomes, Paterson, Henry), University of Toronto; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto; Faculty of Arts and Sciences (Mastorakos), University of Toronto, Toronto, Ont.; Department of Family Medicine (Paterson), McMaster University, Hamilton, Ont.; College of Pharmacy (Sketris), Dalhousie University, Halifax, NS; Faculty of Health Sciences (Caetano), University of Manitoba; Provincial Drug Programs (Caetano), Government of Manitoba, Winnipeg, Man.; Centre for Research in Evidence-Based Practice (Henry), Bond University, Gold Coast, Australia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Mastorakos
Li Ka Shing Knowledge Institute of St. Michael's Hospital (Gomes); Institute for Clinical Evaluative Sciences (Gomes, Paterson, Greaves, Henry); Institute of Health Policy, Management, and Evaluation (Gomes, Paterson, Henry), University of Toronto; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto; Faculty of Arts and Sciences (Mastorakos), University of Toronto, Toronto, Ont.; Department of Family Medicine (Paterson), McMaster University, Hamilton, Ont.; College of Pharmacy (Sketris), Dalhousie University, Halifax, NS; Faculty of Health Sciences (Caetano), University of Manitoba; Provincial Drug Programs (Caetano), Government of Manitoba, Winnipeg, Man.; Centre for Research in Evidence-Based Practice (Henry), Bond University, Gold Coast, Australia
HBSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Michael Paterson
Li Ka Shing Knowledge Institute of St. Michael's Hospital (Gomes); Institute for Clinical Evaluative Sciences (Gomes, Paterson, Greaves, Henry); Institute of Health Policy, Management, and Evaluation (Gomes, Paterson, Henry), University of Toronto; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto; Faculty of Arts and Sciences (Mastorakos), University of Toronto, Toronto, Ont.; Department of Family Medicine (Paterson), McMaster University, Hamilton, Ont.; College of Pharmacy (Sketris), Dalhousie University, Halifax, NS; Faculty of Health Sciences (Caetano), University of Manitoba; Provincial Drug Programs (Caetano), Government of Manitoba, Winnipeg, Man.; Centre for Research in Evidence-Based Practice (Henry), Bond University, Gold Coast, Australia
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingrid Sketris
Li Ka Shing Knowledge Institute of St. Michael's Hospital (Gomes); Institute for Clinical Evaluative Sciences (Gomes, Paterson, Greaves, Henry); Institute of Health Policy, Management, and Evaluation (Gomes, Paterson, Henry), University of Toronto; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto; Faculty of Arts and Sciences (Mastorakos), University of Toronto, Toronto, Ont.; Department of Family Medicine (Paterson), McMaster University, Hamilton, Ont.; College of Pharmacy (Sketris), Dalhousie University, Halifax, NS; Faculty of Health Sciences (Caetano), University of Manitoba; Provincial Drug Programs (Caetano), Government of Manitoba, Winnipeg, Man.; Centre for Research in Evidence-Based Practice (Henry), Bond University, Gold Coast, Australia
PharmDMPA(HSA)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Caetano
Li Ka Shing Knowledge Institute of St. Michael's Hospital (Gomes); Institute for Clinical Evaluative Sciences (Gomes, Paterson, Greaves, Henry); Institute of Health Policy, Management, and Evaluation (Gomes, Paterson, Henry), University of Toronto; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto; Faculty of Arts and Sciences (Mastorakos), University of Toronto, Toronto, Ont.; Department of Family Medicine (Paterson), McMaster University, Hamilton, Ont.; College of Pharmacy (Sketris), Dalhousie University, Halifax, NS; Faculty of Health Sciences (Caetano), University of Manitoba; Provincial Drug Programs (Caetano), Government of Manitoba, Winnipeg, Man.; Centre for Research in Evidence-Based Practice (Henry), Bond University, Gold Coast, Australia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Greaves
Li Ka Shing Knowledge Institute of St. Michael's Hospital (Gomes); Institute for Clinical Evaluative Sciences (Gomes, Paterson, Greaves, Henry); Institute of Health Policy, Management, and Evaluation (Gomes, Paterson, Henry), University of Toronto; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto; Faculty of Arts and Sciences (Mastorakos), University of Toronto, Toronto, Ont.; Department of Family Medicine (Paterson), McMaster University, Hamilton, Ont.; College of Pharmacy (Sketris), Dalhousie University, Halifax, NS; Faculty of Health Sciences (Caetano), University of Manitoba; Provincial Drug Programs (Caetano), Government of Manitoba, Winnipeg, Man.; Centre for Research in Evidence-Based Practice (Henry), Bond University, Gold Coast, Australia
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Henry
Li Ka Shing Knowledge Institute of St. Michael's Hospital (Gomes); Institute for Clinical Evaluative Sciences (Gomes, Paterson, Greaves, Henry); Institute of Health Policy, Management, and Evaluation (Gomes, Paterson, Henry), University of Toronto; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto; Faculty of Arts and Sciences (Mastorakos), University of Toronto, Toronto, Ont.; Department of Family Medicine (Paterson), McMaster University, Hamilton, Ont.; College of Pharmacy (Sketris), Dalhousie University, Halifax, NS; Faculty of Health Sciences (Caetano), University of Manitoba; Provincial Drug Programs (Caetano), Government of Manitoba, Winnipeg, Man.; Centre for Research in Evidence-Based Practice (Henry), Bond University, Gold Coast, Australia
MBChB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Ka Shing Knowledge Institute of St. Michael's Hospital (Gomes); Institute for Clinical Evaluative Sciences (Gomes, Paterson, Greaves, Henry); Institute of Health Policy, Management, and Evaluation (Gomes, Paterson, Henry), University of Toronto; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto; Faculty of Arts and Sciences (Mastorakos), University of Toronto, Toronto, Ont.; Department of Family Medicine (Paterson), McMaster University, Hamilton, Ont.; College of Pharmacy (Sketris), Dalhousie University, Halifax, NS; Faculty of Health Sciences (Caetano), University of Manitoba; Provincial Drug Programs (Caetano), Government of Manitoba, Winnipeg, Man.; Centre for Research in Evidence-Based Practice (Henry), Bond University, Gold Coast, Australia
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 5 no. 4 E800-E807
DOI 
https://doi.org/10.9778/cmajo.20170104
PubMed 
29167237
History 
  • Published online November 22, 2017.
Copyright & Usage 
Copyright 2017, Joule Inc. or its licensors

Author Information

  1. Tara Gomes, PhD,
  2. Andrea Mastorakos, HBSc,
  3. J. Michael Paterson, MSc,
  4. Ingrid Sketris, PharmD, MPA(HSA),
  5. Patricia Caetano, PhD,
  6. Simon Greaves, MSc,
  7. David Henry, MBChB,
  8. for the Canadian Network for Observational Drug Effect Studies Investigators
  1. Affiliations: Li Ka Shing Knowledge Institute of St. Michael's Hospital (Gomes); Institute for Clinical Evaluative Sciences (Gomes, Paterson, Greaves, Henry); Institute of Health Policy, Management, and Evaluation (Gomes, Paterson, Henry), University of Toronto; Leslie Dan Faculty of Pharmacy (Gomes), University of Toronto; Faculty of Arts and Sciences (Mastorakos), University of Toronto, Toronto, Ont.; Department of Family Medicine (Paterson), McMaster University, Hamilton, Ont.; College of Pharmacy (Sketris), Dalhousie University, Halifax, NS; Faculty of Health Sciences (Caetano), University of Manitoba; Provincial Drug Programs (Caetano), Government of Manitoba, Winnipeg, Man.; Centre for Research in Evidence-Based Practice (Henry), Bond University, Gold Coast, Australia
  1. Correspondence to:
    Tara Gomes, GomesT{at}smh.ca
View Full Text

Usage statistics: November 2017 to August 2025

AbstractFullPdf
Nov 201711249763
Dec 201719112543
Jan 2018573624
Feb 2018436525
Mar 2018547619
Apr 20184012328
May 2018375611
Jun 201815504
Jul 2018154914
Aug 201826654
Sep 20182510910
Oct 2018201156
Nov 2018261106
Dec 201816865
Jan 20192010814
Feb 20191212312
Mar 20192915113
Apr 20191816517
May 20191814615
Jun 20191915913
Jul 20193415222
Aug 20192513416
Sep 20192816519
Oct 20193013929
Nov 20193121618
Dec 2019138911
Jan 20201213112
Feb 20201718114
Mar 20201711112
Apr 202079711
May 20207617
Jun 202015424
Jul 202010182
Aug 202016322
Sep 2020195111
Oct 2020224411
Nov 202096211
Dec 202019377
Jan 202119456
Feb 20219373
Mar 202117405
Apr 20218342
May 20211911412
Jun 202116408
Jul 20211687
Aug 202115510
Sep 20213668
Oct 202137130
Nov 202109937
Dec 202151609
Jan 202258511
Feb 20228539
Mar 2022136214
Apr 202275313
May 202244818
Jun 202225220
Jul 202225636
Aug 20226868
Sep 202266729
Oct 202266915
Nov 20224554
Dec 202254310
Jan 202355811
Feb 20230477
Mar 20232337
Apr 20233241
May 20237238
Jun 20239436
Jul 202323112
Aug 20234756
Sep 20235739
Oct 202376013
Nov 202305612
Dec 202336713
Jan 20245446
Feb 202425111
Mar 202445417
Apr 202416115
May 202421598
Jun 202446615
Jul 202456012
Aug 202425019
Sep 202437518
Oct 202426020
Nov 202416721
Dec 202444919
Jan 202516120
Feb 202515821
Mar 2025612637
Apr 2025110422
May 202559724
Jun 202535429
Jul 2025478540
Aug 202527630
PreviousNext
Back to top

In this issue

CMAJ Open: 5 (4)
Vol. 5, Issue 4
21 Dec 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
Tara Gomes, Andrea Mastorakos, J. Michael Paterson, Ingrid Sketris, Patricia Caetano, Simon Greaves, David Henry, for the Canadian Network for Observational Drug Effect Studies Investigators
Nov 2017, 5 (4) E800-E807; DOI: 10.9778/cmajo.20170104

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
Tara Gomes, Andrea Mastorakos, J. Michael Paterson, Ingrid Sketris, Patricia Caetano, Simon Greaves, David Henry, for the Canadian Network for Observational Drug Effect Studies Investigators
Nov 2017, 5 (4) E800-E807; DOI: 10.9778/cmajo.20170104
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Time trends and patterns in opioid prescription use following orthopaedic surgery in Ontario, Canada, from 2004/2005 to 2017/2018: a population-based study
  • The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis
  • Prescription opioid use among drivers in British Columbia, 1997-2016
  • Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
  • Google Scholar

Similar Articles

Collections

  • Clinical
    • Drugs
      • Drug misuse
      • Regulation
    • Anesthesia & Analgesia
      • Pain (including opioids)

Content

  • Current issue
  • Past issues
  • Collections

About

  • General Information
  • Staff
  • Editorial Board
  • Advisory Panel
  • Contact Us
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire